Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 3 1

Status

Unknown 4Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

regorafenib 2Radiofrequency Ablation 1Nivolumab 1Irinotecan 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Colorectal Cancer Liver Metastases × Clear all
NCT05873972 2023-05-24

Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis Patient

Fudan University

Phase NA Unknown
100 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

NCT05794971 2023-05-15

RIDER

Sun Yat-sen University

Phase 3 Recruiting
126 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

NCT04272931 2023-02-03

DRAGON

Maastricht University

Phase NA Unknown
111 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

NCT05588297 2022-10-20

Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases

Shanghai Changzheng Hospital

Phase 2 Unknown
12 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

NCT05485909 2022-08-03

Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM

Sun Yat-sen University

Phase 2 Unknown
32 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡